Dermatologic

RSS

Step Pharma identifies new CTP synthase 1 inhibitors

May 13, 2020

FDA clears IND for phase Ib/IIa study of HST-001 for androgenic alopecia

May 12, 2020

Health Canada clears phase I trial of AC-1101 for vitiligo

May 8, 2020

Amgen reports topline data from phase III study of Otezla for mild to moderate plaque psoriasis

May 7, 2020

Unigen divulges tyrosinase and melanin inhibitors

May 6, 2020

Phase II trial of nomacopan in bullous pemphigoid meets primary and key secondary efficacy endpoints

May 4, 2020

Pfizer discloses new PDE4B inhibitors

April 24, 2020

Phase IIb study of Rivelin-CLO achieves primary endpoint

April 24, 2020

Amryt closes enrollment in phase III EASE trial of AP-101 for epidermolysis bullosa

April 23, 2020

Phase II study of vixarelimab in prurigo nodularis meets primary efficacy endpoint

April 23, 2020